HomeADVANCE › Filing
🔔 Get instant alerts when ADVANCE files quarterly results on BSE Start free trial →

Press Release for the Unaudited Financial Results of the Company for the Quarter ended on June 30, 2026

Filed: 06 Aug 2026, 17:48 IST Exchange: BSE Category: Financial Results — Press Release
Press Release - Q1FY27 - Revenue 3.304bn +96% y-y; EBITDA 351m +105% y-y (margin 10.6%, +50 bps y-y); PAT 225.5m +152% y-y - Q-o-Q revenue up 167%, EBITDA up 162%, PAT up 202% - New Unit-4 technical manufacturing facility at Gidani to start by Q3 FY27 - Construction started for Unit-5 manufacturing facility at Dahej, Gujarat, to boost capacity - CMD: Strong operational foundation and growth strategy support optimistic FY27 outlook
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ADVANCE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ADVANCE to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Advance Agrolife Limited

Important. The summary above is generated automatically from Advance Agrolife Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.